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Abstract
The synthetic control method is often used in treatment effect estimation with panel data where only
a few units are treated and a small number of post-treatment periods are available. Current estimation
and inference procedures for synthetic control methods do not allow for the existence of spillover effects,
which are plausible in many applications. In this paper, we consider estimation and inference for synthetic
control methods, allowing for spillover effects. We propose estimators for both direct treatment effects
and spillover effects and show they are asymptotically unbiased. In addition, we propose an inferential
procedure and show it is asymptotically unbiased. Our estimation and inference procedure applies to cases
with multiple treated units and/or multiple post-treatment periods, and to ones where the underlying
factor model is either stationary or cointegrated. In simulations, we confirm that the presence of spillovers
renders current methods biased and have distorted sizes, whereas our methods yield properly sized tests
and retain reasonable power. We apply our method to a classic empirical example that investigates the
effect of California’s tobacco control program as in Abadie et al. (2010) and find evidence of spillovers.
1 Introduction
The synthetic control method is often used in treatment effect estimation with panel data where only a
few units are treated and a small number of post-treatment periods are available. Current estimation
and inference procedures for synthetic control methods do not allow for the existence of spillover effects,
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which are plausible in many applications. This paper alleviates these concerns by showing that given
some knowledge about the spillover effects, it is possible to provide asymptotically unbiased estimators
and inference in the presence of spillovers. Our results extend to scenarios with multiple treated units
and periods, and cases with stationary or cointegrated factor models.
The synthetic control method (SCM) has gained popularity in empirical studies since its introduction
in Abadie and Gardeazabal (2003). When we observe panel data with only a few treated units and
post-treatment periods, the SCM can estimate treatment effects. This setting is common in program
evaluation, where we often consider state-level policies and have state-level aggregate data. The SCM
models the relationship between the treated and untreated units using pre-treatment data. Then the
SCM uses the post-treatment data from untreated units to predict the counter-factual values of the
treated unit. This process gives us the synthetic control, while the difference between the outcome and
predicted counter-factual outcome is the treatment effect estimate. The SCM exploits the pre-treatment
data to form better counter-factual values, and so in comparative case studies it is often favored over
other program evaluation methods such as difference-in-differences. See Abadie and Cattaneo (2018) for
review and comparison of econometric methods used in program evaluation.
However, the SCM and its variants assume explicitly or implicitly that untreated units are not affected
by the treatment. That is, they rely on the Stable Unit Treatment Value Assumption (SUTVA). This
dependence is natural since the SCM uses post-treatment control units to predict the counter-factual
values of the treated units, which, however, is not always realistic. In our empirical example in Section
6, when California imposes a cigarette tax, SUTVA implies (among other things) that nobody decides
to shift their cigarette purchases to Nevada.
Under SUTVA and a few other regularity conditions within a factor model, treatment effect estimators
using a demeaned version of SCM are shown to be inconsistent but asymptotically unbiased by Ferman
and Pinto (2019), even when the pre-treatment fit is imperfect. Unfortunately, in the presence of a
spillover effect, this estimator can be severely biased. Intuitively, the reason is that post-treatment
controls are contaminated by the spillover effect, resulting in a biased estimator of the counter-factual
value of the treated unit in post-treatment periods, which implies a biased treatment effect estimate.
Contamination inducing bias is a standard problem in program evaluation, even within difference-in-
differences and RCTs. This problem is worse for the SCM. If by chance the spillover is concentrated in
control units that the synthetic control method puts significant weight on, the bias will be substantially
worse than in difference-in-differences. Moreover, it is possible the spillovers propagate along the same
channels as the underlying factor model, which would mean that the SCM may actively select for units
which will induce bias. In our simulation section, we will explore this bias in more depth.
It is worth noting that the problem caused by spillover effects cannot fully solved by na¨ıve methods
such as not including contaminated units in estimation. This is because the contaminated units are
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often the most important control units that can be useful in forming the synthetic control. Simply not
including them in estimation can potentially cause efficiency loss. Moreover, there are cases where most
or even all control units are affected by the spillover, which cannot be solved by throwing away affected
control units. This is also true for synthetic control methods that are modified to estimate treatment
effects with multiple treated units, since the current methods in the literature use only the units that
are not affected by the treatment in order to form the synthetic control. For examples of multivariate
synthetic control methods, see Cavallo et al. (2013), Firpo and Possebom (2018), Kreif et al. (2016),
Robbins et al. (2017), and Xu (2017).
The goal of this paper is to relax the SUTVA condition and to perform estimation and testing. Par-
ticularly, we look at the cases where there are spillover effects, which are defined by a Rubin model as
the difference between the actual outcomes and the counterfactual ones. To facilitate estimation, we
assume some knowledge about the spillover effects is known. More specifically, the treatment effect and
the spillover effects are linear in some unknown parameters. We give examples where this assumption is
plausible. For each unit of observation, we estimate a model between it and all the other units, using
the SCM with pre-treatment data. Thanks to the known spillover structure, we obtain asymptotically
unbiased estimators for the treatment and spillover effects. We also characterize the asymptotic distri-
bution of the estimator. Unlike the current methods, our method uses information from all control units
in estimation.
In addition, we propose an inferential procedure based on Andrews (2003)’s end-of-sample instability
test, or P -test. We first generalize the P -test to the synthetic control method without spillover effects
and then generalize it further to incorporate cases with spillover effects. Similar to the P -test, our testing
procedures use the idea of approximating the null distribution of the statistic using pre-treatment data.
We give high-level conditions under which our methods are valid. Specifically, our conditions adapt
to factor models with either stationary or cointegrated common factors, which are often used to justify
the usage of synthetic control methods. Furthermore, we consider extensions where treatment applies to
multiple units or periods, and where there are extra covariates.
We examine an empirical example from Abadie et al. (2010). In 1989 California implemented a
cigarette tax. Abadie et al. (2010) gather data from 38 states starting in 1970 for comparison. They
dismiss 12 states for potentially being affected by spillovers or later treatment. Despite this precaution,
we find evidence of spillover effects in every year after 1990. Moreover, those spillovers appear to have a
substantial impact on the treatment effect estimate in 4 of the first 5 years after treatment.
This paper mainly contributes to three developing literatures. First, it complements the fast-developing
literature on synthetic control inference by relaxing SUTVA. Due to its popularity among empirical re-
searchers, many formal results have been developed for statistical inference in similar settings. For
example, Conley and Taber (2011) consider hypothesis testing in a similar data structure where only a
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few units are treated and both pre- and post-treatment periods are short. They consider difference-in-
differences, and use control units to form the null distribution of the statistic. In this particular setting
with only a few treated units, difference-in-difference estimator can be treated as a speical case of the
SCM with equal weights. In Ferman and Pinto (2017) and Hahn and Shi (2017), similar ideas are used
to conduct placebo tests which permute across observed units. Among all, Chernozhukov et al. (2017)
is the most related to our work, since they also use outcomes across periods rather than across units
like the above citations. Li (2019) proposes a testing procedure that is based on the idea of projection
onto convex sets and results in Fang and Santos (2018). However, none of the papers mentioned above
allows for the existence of spillover effects. Our methods provide formal statistical results in this setting,
without assuming SUTVA. Furthermore, our estimation and testing procedure applies to factor models
with cointegrated common factors, which is of special interest even in cases without spillover effects.
We also contribute to the literature on spillover effects. This fast-growing literature looks into both
estimation of treatment effects in the presence of spillover effects, as well as estimation of spillover effects
themselves. For example, Vazquez-Bare (2017) consider a framework where observations are grouped into
clusters, and spillover effects are allowed within a cluster, but not across clusters. It discusses estimation
of heterogeneous treatment effects as a function of the number of treated units within the same cluster,
and spillover effects as a function of whether the unit is treated, and number of treated units within
the same cluster. Basse et al. (2017) and Rosenbaum (2007) use randomization test for inference in the
presence of spillover effects. Also see Basse et al. (2017) and Vazquez-Bare (2017) for a literature review
on spillover effects. However, this literature seldom looks at the panel data setting with only a few treated
units and short post-treatment periods. This limitation is in part because we usually do not have enough
information about the spillover effects in this particular setting. We overcome this problem by requiring
a potentially weak assumption that the spillover structures be pre-specified and follow a pattern that is
linear in some underlying parameters. With that specification, we can estimate the spillover effects and
perform statistical tests on the spillovers.
Third, our results extend the literature on Andrews (2003)’s end-of-sample instability tests. Andrews
(2003) uses data across time periods to approximate the null distribution of the test statistic, and apply
this idea to OLS, IV, and GMM. Chernozhukov et al. (2017) propose a permutation test that is more
general, but similar in cases where serial correlation matters. We extend this idea to the the SCM
case, and further to more complicated cases with spillover effects. As Andrews and Kim (2006) extends
Andrews (2003)’s results to the cointegrated cases, we also show that our method is still valid for a
cointegrated factor model.
The remainder of this paper is organized as follows. Section 2 introduces a factor model with spillover
effects, proposes an estimator of the spillover effects and derives its asymptotic distribution. Section 3
considers the P -test introduced by Andrews (2003) and Andrews and Kim (2006), and explains how it
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↑ treatment
Figure 1
can be applied in our settings, with proofs in the Appendix. Section 4 extends our methods to cases
with multiple treated units and/or multiple post-treatment periods, and briefly discusses cases with
extra covariates. We present Monte Carlo simulation results in Section 5 and in Section 6 we present an
empirical example of our method. Section 7 concludes. All proofs are in the appendix.
2 Model and Estimation
2.1 A Rubin Model with spillover effects
We consider Rubin’s potential outcome model. In Rubin’s model with violation of SUTVA, the potential
outcomes are functions of treatment assignments on all units. Namely, the outcome of unit i at time t is
yi,t = yi,t(dt),
where dt = (d1,t, . . . , dN,t)
′ and di,t = 1 if unit i has been treated at time t.
We consider a standard synthetic control setting where only one unit is treated and only one period is
available after the treatment is implemented. We consider cases with multiple treated units and multiple
post-treatment periods in Section 4. Let unit 1 be treated between time T and T + 1, and there be
another N − 1 units that are not directly treated by the policy. Thus, we observe an N × (T + 1) panel
as shown in Figure 1.
Note that we only observe outcomes with dT+1 = (0, . . . , 0)
′ or dT+1 = (1, 0, . . . , 0)′. This is the
fundamental limitation of the dataset we are currently studying. Unless other homogeneity conditions
are assumed, we cannot say anything about yi,T+1(dT+1) for dT+1 6∈ {(0, . . . , 0)′, (1, 0, . . . , 0)} because
only a few units are treated and only a few post-treatment periods are available. For notation simplicity,
let 
yi,t(0) = yi,t(0, . . . , 0)
yi,t(1) = yi,t(1, 0, . . . , 0)
for each (i, t). Let αi = yi,T+1(1) − yi,T+1(0) be the potential deviation from unit i’s counterfactual
outcome yi,T+1(0) where no unit is treated at time T + 1. That is, α1 is the direct treatment effect on
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unit 1, while αi with i 6= 1 is the indirect effect or spillover effect. Throughout, we consider the case
where N is fixed and T goes to infinity.
In case studies, we are often interested in estimating the treatment effect α1. For example, Abadie
et al. (2010) consider the direct treatment effect on California of the tobacco control policy implemented
in the state. A common choice is the synthetic control estimator. Namely, we obtain the synthetic control
weights by solving the optimization problem
â1
b̂1
 = arg min
a˜∈R,b˜∈W (1)
T∑
t=1
(yi,t − a˜− Y ′t b˜)2, (1)
where Yt = (y1,t, . . . , yN,t)
′ and W (1) = {(w1, . . . , wN )′ ∈ RN+ : w1 = 0,
∑N
j=2 wj = 1}. An estimator of
the treatment effect α1 is given by
α̂1 = y1,T+1 − (â+ Y ′T+1b̂),
i.e., the counter-factual value y1,T+1(0) is approximated by â+Y
′
T+1b̂. For this paper we use an constraint
set as in the demeaned synthetic control method (Ferman and Pinto, 2019). That is, we do not restrict
the intercept but require the other coefficients to be positive and sum up to one. 1
2.2 Assumptions
2.2.1 spillover structure
Throughout the paper, we assume some knowledge about the spillover effects is known. Namely, assume
that the full effect vector α is a linear transformation of some unknown parameter γ ∈ Rk, i.e. α = Aγ.
Typically, γ has less dimensions than α does. Here are some examples that fit in this framework.
Example 1. Assume a subset of control units, but not all of them, are equally affected by the spillover
effects, i.e.
A =

1 0
0 1
...
...
0 1
0 0
...
...
0 0

, γ =
α1
b
 .
1Other choices of constraint set for (â1, b̂′1)
′ include {0}×{0}×∆N−1 as in the original synthetic control method of Abadie
and Gardeazabal (2003) and Abadie et al. (2010), and R×{0}×RN−1+ as in the modified synthetic control of Li (2019), where
∆N−1 = {w ∈ RN−1 : wi ≥ 0 for each i,
∑N−1
i=1 wi = 1} is a (N − 1)-dimensional simplex. See Doudchenko and Imbens (2016)
for a discussion of other restriction sets.
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Example 2. Assume the spillover effect shrinks as the geometric distance goes up. For i = 2, . . . , N ,
αi = b exp(−di) where di is the distance between unit 1 and unit i and b is some unknown parameter of
interest. Then, we have
A =

1 0
0 exp(−d2)
...
...
0 exp(−dN )

, γ =
α1
b
 .
Example 3. Assume the spillover effect is likely to take place at some known locations, but not at other
locations, while the sizes of spillover effects are allowed to vary across those units. For example, assume
there are potential spillovers at locations whose distance to unit 1 is less than d¯. Then, the treatment and
spillover effect vector can also be represented by Aγ. WLOG order the units by increasing distance from
unit 1, and let p the number of units experiencing spillovers. Then
A =

1 01×p
0p×1 Ip
0(N−p−1)×1 0(N−p−1)×p
 , γ =

α1
αk1
...
αkp

.
Thus the units indexed 2, ..., (p+ 1) each experience their own size spillover effect.
The assumptions in Example 3 are often plausible. We give an empirical example in Section 6. If mis-
specification of the spillover structure is a concern, one can always choose an A matrix that incorporates
more potential spillovers, i.e., a bigger p.
2.2.2 invertibility assumption
In order to back out the spillover effects, we proceed as follows. We first define the individual synthetic
control weights and their limits. Namely, let
âi
b̂i
 = arg min
a˜∈R,b˜∈W (i)
T∑
t=1
(yi,t − a˜− Ytb˜′)2, (2)
where W (i) = {(w1, . . . , wN )′ ∈ RN+ : wi = 0,
∑N
j=1 wj = 1}. Then, let
ai = plim âi, bi = plim b̂i,
and we only consider cases where they are well-defined. We show later by Lemma 1 that ai and bi exist
for each i in factor models with stationary or cointegrated common factors. In general, ai and bi do not
coincide with the weights that reconstruct the factor loadings (Ferman and Pinto, 2019).
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For each (i, t), define the specification error by
ui,t = yi,t(0)− (ai + Yt(0)′bi). (3)
Note that the i-th entry of bi is zero. Define a = (a1, . . . , aN )
′, B = (b1, . . . , bN )′, andM = (I−B)′(I−B).
Stacking Equation (3) for all i’s gives
ut = Yt(0)− (a+BYt(0)),
where and ut = (u1,t, . . . , uN,t)
′. For t = T + 1, this becomes
uT+1 = (I −B)(YT+1 − α)− a, (4)
where YT+1 = (y1,T+1, . . . , yN,T+1)
′. We will use this equation to estimate the spillover effect.
Defining M = (I −B)′(I −B), we introduce the following invertibility assumption:
Condition IN. A′MA is non-singular.
First note Condition IN is testable in principle. We can consistently estimate B so the data informs
us of the validity of this assumption. To understand this assumption better, we replace α by Aγ in
Equation (4) and have
(I −B)Aγ = (I −B)YT+1 − a− uT+1. (5)
Equation (5) is the key to learning α. Under mild regularity conditions, a and B are identified from
the model and learned by the synthetic control method. We do not observe uT+1, but the distribution
of uT+1 can be learned using pre-treatment data under stationarity of {ut}t≥1. Therefore, if A′MA
is non-singular, or equivalently, (I − B)A has full rank, we can form an estimator of γ whose limiting
distribution is identified by multiplying both sides of Equation (5) by (A′MA)−1A′(I − B)′. Note that
we do not identify γ or α. This is because we have only one observation of the outcome in post-treatment
periods.
We illustrate Condition IN in the following toy example.
Example 4. Assume there are 3 units in total, where unit 1 is treated. Let the synthetic control weight
matrix B be
B =

0 w1 1− w1
w2 0 1− w2
w3 1− w3 0
 .
Suppose the researcher first assumes unit 2 and 3 are equally exposed to the spillover effects. That is,
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they assume
A1 =

1 0
0 1
0 1
 , γ =
 γ1
γ2
 , and α =

γ1
γ2
γ2
 .
Then, Condition IN does not hold, because
(I −B)A1 =

1 −1
−w2 w2
−w3 w3
 .
If they instead assumes only one of the controls is exposed to the spillover effects, Condition IN is satisfied
in general. In this case,
A2 =

1 0
0 1
0 0
 , γ =
 γ1
γ2
 , and α =

γ1
γ2
0
 ,
and
(I −B)A2 =

1 −w1
−w2 1
−w3 w3 − 1
 .
It can be shown that (I −B)A2 always has full rank for (w1, w2, w3) ∈ [0, 1]3.
This applies to more general settings. That is, if all controls are equally hit by the spillover effects,
then (I−B)A does not have full rank and we lose Condition IN. Allowing a few units to be exempt from
the spillover effects makes (I −B)A have full rank in general.
A more interesting case is Example 3, where we only restrict the range of spillover effects and allow
the levels to vary. In this case, (I − B)A can be obtained by eliminating columns that correspond to
units that are neither treated nor exposed to spillover effects. Again, as long as at least one control is not
exposed to the spillover effects, (I − B)A has full rank in general. This assumption is more convincing
if a moderate number of columns are eliminated from (I − B), i.e. only a few units are exposed to the
spillover effects.
2.3 Estimation
We form estimators for (a,B) using synthetic control methods as in (2). We do that for each i = 1, . . . , N ,
as if each i is the treated unit and other units are controls. Then, the estimators for a and B are
â = (â1, . . . , âN )
′ and B̂ = (̂b1, . . . , b̂N )′ respectively. Let M̂ = (I − B̂)′(I − B̂) be an estimator for M .
9
Let an estimator of γ be such that
γ̂ = arg min
g∈Rk
‖(I − B̂)(YT+1 −Ag)− â‖
= (A′M̂A)−1A′(I − B̂)′((I − B̂)YT+1 − â). (6)
Note that the FOC implies
A′(I −B)′uT+1 = 0,
i.e. it requires that some weighted sum of the residuals to be zero. Under that condition, the treatment
and spillover effect vector α can be estimated by α̂ = Aγ̂.
Assumption 1. (a) {ut}t≥1 is stationary, and has mean zero.
(b) ‖â− a‖ = op(1), ‖B̂ −B‖ = op(1)
(c) ‖(B̂ −B)YT+1(0)‖ = op(1).
(d) A′MA is non-singular.
Note that Part (c) excludes polynomial time trends.
Theorem 1. Suppose Assumption 1 holds. Then, α̂ − (α + GuT+1) →p 0 as T → ∞, where G =
A(A′MA)−1A′(I −B)′. Moreover, E[GuT+1] = 0.
The structure of the limiting distribution is similar to the case as in Ferman and Pinto (2019), as it
is inconsistent but asymptotically unbiased (i.e. that the difference between the estimator and the true
value has zero mean). Note that consistent estimators are impossible because only one post-treatment
period is available.
Moreover, we can form an estimator of α with possibly lower variance. For some positive definite
matrix W ∈ RN , we minimize ‖W 1/2T+1‖ instead of ‖T+1‖. The resulting estimator is
γ̂W = arg min
g∈Rk
‖W 1/2((I − B̂)(YT+1 −Ag)− â)‖
= (A′M̂WA)
−1A′(I − B̂)′W ((I − B̂)YT+1 − â),
where M̂W = (I− B̂)′W (I− B̂). The corresponding estimator for α is α̂W = Aγ̂W . In the spirit of GMM
with an efficient weighting matrix, let Ω = Cov[u1] and W
e
T be a consistent estimator of Ω
−1. Then an
estimator of α with lower variance can be achieved by α̂e = α̂We
T
.
Let MW = (I − B)′W (I − B), GW = A(A′MWA)−1A′(I − B)′W for some weighting matrix W ,
W e = Ω−1, Me = MWe , and Ge = GWe . Then, we have the following results.
Proposition 1. Suppose Assumption 1 holds, WT is a consistent estimator for W , and W
e
T is a consistent
estimator for W e. Then, α̂WT − (α + GWuT+1) →p 0, and specifically, α̂e − (α + GeuT+1) →p 0, as
T →∞. Moreover, (Cov[GWuT+1]− Cov[GeuT+1]) is positive semi-definite.
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In practice, we need to estimate Ω, and for that we would need relatively large sample size (large T )
to have a good approximation.
2.4 The factor model as an example
Factor models are often used to justify the usage of synthetic control methods. Here we show that our
assumptions are satisfied by factor models with stationary and cointegrated common factors. We follow
Ferman and Pinto (2019) and consider a factor model such that for i = 1, . . . , N and t = 1, . . . , T + 1,
yi,t(0) = ηt + λ
′
tµi + i,t, (7)
where λt is F -dimensional common factors, and i,t is noise that is uncorrelated with λt. For notation
simplicity, we write Yt(0) = (y1,t(0), . . . , yn,t(0))
′, Yt = (y1,t, . . . , yn,t)′, and t = (1,t, . . . , n,t)′.
We focus on two sets of conditions in our discussion.
Condition ST (model with stationary common factors). Assume {(ηt, λt, t)}t≥1 is stationary, ergodic
for the first and second moments, and has finite (2+δ)-moment for some δ > 0. Assume cov[Yt(0)] = Ωy
is positive definite.
Remarks: 1. We show in the proof of Lemma 1 that in this case
bi = arg min
w∈W (i)
(w − ei)′Ωy(w − ei),
ai = E[yi,1(0)− Y1(0)′bi],
where ei is a unit vector with one at the i-th entry and zeros everywhere else, and W
(i) = {(w1, . . . , wN ) ∈
RN+ : wi = 0,
∑
j 6=i wj = 1}. Note that in general bi does not recover the factor structure, because
µi 6= (µ1, . . . , µN )bi in general.
2. We do not impose any restriction on the factor loadings {µi}Ni=1 except for Ωy being positive
definite. In the stationary case, the key for the treatment estimator to be asymptotically unbiased and
the test proposed below to be valid is to include an intercept in the optimization problem (2).
Condition CO (model with cointegrated I(1) common factors). Rewrite Equation (7) as
yi,t(0) = (λ
1
t )
′µ1i + (λ
0
t )
′µ0i + i,t,
and ηt can be either in λ
1
t or λ
0
t . Assume {(λ0t , t)}t≥1 is stationary, ergodic for the first and second
moments, and has finite 4-th moment. Without loss of generality, E[i,t] = 0. Assume {λ1t}t≥1 is I(1).
Further assume for each i, yi,t(0) is such that weak convergence holds for T
−1/2yi,[rT ](0)⇒ νi(r), where
⇒ is weak convergence and process νi(r) is defined on [0, 1] and has bounded continuous sample path
almost surely. For each i, let W (i) = {(w1, . . . , wN ) ∈ RN+ : wi = 0,
∑
j 6=i wj = 1}. Assume for each i,
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there exists w(i) ∈ W (i) such that µ1i =
∑N
j=1 w
(i)
j µ
1
j . That is, (w
(i) − ei) is a cointegrating vector for
Yt(0), where ei is a unit vector with i-th entry being one and zeros everywhere else.
Note that Condition CO puts restrictions on the factor loadings. The restrictions are similar to those
in Ferman and Pinto (2019).
The relevance of the factor model is given by the following lemma:
Lemma 1. Under Condition IN, either Condition ST or Condition CO implies Assumption 1.
Thus, results derived in Thereom 1 apply to factors models with Condition ST or Condtion CO.
3 Inference
In this section, we discuss formal results on inference. At a high level, our test uses pre-treatment data to
form the null distribution of a pre-specified post-treatment quantity. Flexibility in defining that quantity
leads to a variety of hypotheses. In Section 3.1, we consider the case without spillover effects, and state
the assumptions under which Andrews’ P test (Andrews, 2003) is valid. In Section 3.2, we generalize P
test to cases where spillover effects cannot be ignored.
3.1 Cases without spillover effects
Suppose for now there are no spillover effects, i.e. α2 = · · · = αN = 0. We want to test for the existence
of treatment effect on unit 1. The null and alternative hypotheses of interest are

H0 : α1 = 0,
H1 : α1 6= 0.
The test procedure we consider here is the end-of-sample instability test (P -test) in Andrews (2003). The
usage of Andrews’ test in the context of synthetic control methods is mentioned in Ferman and Pinto
(2018), where they focus on the difference-in-differences estimator. We formalize this idea and derive
conditions under which Andrews’ test delivers valid inference results.
We assume the α1 is independent of T under H1. That is, we consider fixed, not local, alternatives,
as in Andrews (2003) and Andrews and Kim (2006). Specifically, α1 does not change as T grows, which
facilitates our analysis of the test statistic under H1.
Now we translate our hypothesis into the linear formulation considered in Abadie and Gardeazabal
(2003). Namely, we have
yt =

a1 + Y
′
t b1 + u1,t, for t = 1, . . . , T ,
a∗1 + Y
′
t b1 + u1,t, for t = T + 1.
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A non-zero treatment effect is equivalent to a shift in the intercept a1 (or equivalently, change of the
distribution of u1,t, at t = T + 1). The null and alternative hypothesis become

H0 : a
∗
1 = a1,
H1 : a
∗
1 6= a1.
Let the synthetic control regression residuals be û1,t = y1,t − â1 − Y ′t b̂1. The test statistic is defined by
P = û21,T+1.
For notational simplicity, let β̂1 = (â1, b̂
′
1)
′ and xt = (1, Y ′t )
′. For β ∈ RN+1, define
Pt(β) = (y1,t − x′tβ)2.
Then, P = (y1,T+1 − x′T+1β̂1)2 = PT+1(β̂1). Let P∞ be a random variable with the same distribution as
PT+1(β1) with β1 = (a1, b
′
1)
′. Let Pt = Pt(β̂
(t)
1 ), where β̂
(t)
1 = β̂1 for each t.
2 Define
F̂P,T (x) =
1
T
T∑
t=1
1{Pt ≤ x},
and let FP (x) be the distribution function of P1(β1). Finally, let q̂P,1−τ = inf{x ∈ R : F̂P,T (x) ≥ 1− τ},
and qP,1−τ be the (1− τ)-quantile of P1(β1). The assumptions and validity of the testing procedure are
established as follows.
Assumption 2. (a) {ut}t≥1 are stationary, ergodic, and have mean zero.
(b) E[|ut|] <∞.
(c) ∃ a non-random sequence of positive definite matrices {CT }T≥1 such that maxt≤T+1 ‖C−1T xt‖ = Op(1)
(d) ‖CT (β̂1 − β1)‖ = op(1), and maxt=1,...,T ‖CT (β̂(t)1 − β1)‖ = op(1).
(e) The distribution function of P1(β1) is continuous and increasing at its (1− τ)-quantile.
Theorem 2. Suppose Assumption 2 holds. Then, as T →∞,
(a) P →d P∞ under H0 and H1,
(b) F̂P,T (x)→p FP (x) for all x in a neighborhood of qP,1−τ under H0 and H1,
(c) q̂P,1−τ →p qP,1−τ under H0 and H1,
(d) Pr(P > q̂P,1−τ )→ τ under H0.
In addition, we show the relevance of the factor model in this context by the following lemma:
Lemma 2. Suppose the distribution function of P1(β1) is continuous and increasing at its (1−τ)-quantile.
2Readers can also use leave-one-estimator to construct Pt as in Andrews (2003) and Andrews and Kim (2006). For t =
1, . . . , T , the leave-one-out estimator β̂
(t)
1 is defined by the synthetic control weight estimator using only observations indexed
by s = 1, . . . , t− 1, t+ 1, . . . , T .
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Then, either Condition ST or Condition CO implies Assumption 2.
3.2 Cases with spillover effects
Now we allow for non-zero spillover effects. We propose a testing procedure that is based on Andrews’
P -test and accounts for the spillover effect. The null and alternative hypotheses we consider are H0 :
Cα = d and H1 : Cα 6= d, with C and d known. For example, we want to test for the hypothesis that
there is no treatment effect at the treated unit (unit 1), then we let C = (1, 0, 0, . . . , 0) ∈ R1×N and
d = 0. This effectively makes Section 3.1 a special case of our test, although Theorem 2 has slightly
stronger results than Theorem 3 does. If we want to test that there is a spillover, then we can let
C = [0(N−1)×1 IN−1] ∈ R(N−1)×N and d = (0, . . . , 0)′ ∈ R(N−1)×1.
The test statistic we consider here is P = (Cα̂−d)′WT (Cα̂−d) for some weighting matrix WT →p W .
Recall G = A(A′MA)−1A′(I − B) and can be consistently estimated by Ĝ = A(A′M̂A)−1A′(I − B̂) if
B̂ →p B. By Theorem 1, P is asymptotically equivalent to u′T+1G′C′WCGuT+1. To construct critical
values, define
Pt(θ) = (Yt − θxt)′G′C′WCG(Yt − θxt),
and
P̂t(θ) = (Yt − θxt)′Ĝ′C′WTCĜ(Yt − θxt),
for some θ ∈ RN×(N+1), xt = (1, Y ′t )′, and Ĝ = A(A′M̂A)−1A′(I− B̂)′. Let P̂t = P̂t(θ̂(t)), where θ̂(t) = θ̂
for each t.3 Let P∞ = P1(θ0) for θ0 = [a B]. Define
F̂P,T (x) =
1
T
T∑
t=1
1{P̂t ≤ x},
and let FP (x) be the distribution function of P∞. Finally, let q̂P,1−τ = inf{x ∈ R : F̂P,T (x) ≥ 1−τ}, and
qP,1−τ be the (1 − τ)-quantile of P∞. The assumptions and validity of the proposed testing procedure
are given as follows.
Assumption 3. (a) Assumption 1 holds.
(b) {ut}t≥1 is ergodic and E[‖ut‖] <∞.
(c) There exists a non-random sequence of positive definite matrices {DT }T≥1 such that maxt≤T+1 ‖D−1T xt‖ =
Op(1).
(d) ‖(θ̂ − θ0)DT ‖F = op(1), and maxt=1,...,T ‖(θ̂(t) − θ0)DT ‖F = op(1), where ‖ · ‖F is the Frobenius
norm.
(e) The distribution function of P1(θ0) is continuous and increasing at its (1− τ)-quantile.
(f) WT →p W as T →∞.
3Similar to the case without spillover effects, the leave-one-out estimator θ̂(t) = [â(t) B̂(t)] is defined by the synthetic control
weight estimator using only observations indexed by s = 1, . . . , t− 1, t+ 1, . . . , T .
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(a) No spillover effects
95%
(b) Spillover effects
95%
Figure 2: Placebo test. Area with lines is 95% probability region of the error of the treated unit. Filled area is 95%
probability region of null distribution formed in placebo test. A test is rejected when the error of the treated units
falls outside of the filled area.
Theorem 3. Suppose Assumption 3 holds. Then, under H0, as T →∞,
(a) P →d P∞,
(b) F̂P,T (x)→p FP (x) for all x in a neighborhood of qP,1−τ ,
(c) q̂P,1−τ →p qP,1−τ ,
(d) Pr(P > q̂P,1−τ )→ τ .
Again, we show the relevance of the factor model in this context by the following lemma:
Lemma 3. Suppose the distribution function of P1(θ0) is continuous and increasing at its (1−τ)-quantile.
Then, under Condition IN, Assumption 3 is satisfied if either of these holds:
(i) Condition ST with WT = I or WT = (CĜ(T
−1∑T
t=1 ûtû
′
t)Ĝ
′C′)−1;
(ii) Condition CO with WT = I.
3.3 Other testing procedures
When we allow for existence of non-zero spillover effects, the existing testing procedures will have poor
performance. Here we intuitively explain what happens to placebo test as in Abadie and Gardeazabal
(2003) and Andrews’ test as in Andrews (2003) in the presence of spillover effects.
Suppose we want to test for the treatment effect being zero and are not aware of the spillover effects.
Placebo test and Andrews’ test are similar in the sense that they use data to form the null distribution of
u1,T+1 in order to perform hypothesis testing. The difference is that the placebo test exploits variations
of {ûi,T+1}Ni=1, while Andrews’ test uses variations of {û1,t}T+1t=1 .
We look at the placebo test first. When there is no spillover effect, the distribution of û1,T+1 and
distribution of {ûi,T+1}Ni=2 overlap asymptotically. As shown in Figure 2(b), when there are positive
spillover effects, we will underestimate the treatment effect and the density function of û1,T+1 moves to
the left. At the same time, some of the control units shift to the right because of the positive spillovers,
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(a) No spillover effects
95%
(b) Spillover effects
95%
Figure 3: Andrews’ test. Area with lines is 95% probability region of the error of the treated unit. Filled area is
95% probability region of null distribution formed in Andrews’ test. A test is rejected when the error of the treated
units falls outside of the filled area.
so density of {ûi,T+1}Ni=2 moves to the right and gets wider. In terms of test performance, the shift of
û1,T+1 is offset by the wider density of {ûi,T+1}Ni=2 (harder to reject H0), which explains why in Table
3 of Section 5 the empirical sizes of placebo test for T = 50 and 200 cases are not too far away from the
nominal size 0.05. In essence, the placebo test becomes much more conservative and has low power as
shown in Table 4.
Now we consider Andrews’ test. When there is no spillover effect, the distribution of û1,T+1 and
distribution of {û1,t}Tt=1 overlap asymptotically. As shown in Figure 3(b), when there is positive spillover
effect, we underestimate the treatment effect and the density function of û1,T+1 shifts to the left, while
the density of {û1,t}Tt=1 doesn’t, since they are pre-treatment and the spillover only happens after the
treatment. This results in an invalid test.
4 Extensions
4.1 Multiple treated units
Our method readily extends to cases where multiple units are treated. In our setting, spillover effects are
not distinguished from treatment effects, since one can think of spillover as the treatment on the units
that are not directly treated. With a corrected specified structure matrix A, we can perform estimation
and testing just as previous sections. For example, suppose N = 4, unit 1 and unit 2 are treated, unit 3
is affected by spillover effect, and unit 4 is neither treated nor exposed to spillover effect. Then we can
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specify
A =

1 0 0
0 1 0
0 0 1
0 0 0

,
and the resulting estimator γ̂ = (γ̂1, γ̂2, γ̂3)
′ by (6) is such that γ̂1 and γ̂2 are the treatment effect
estimator for unit 1 and unit 2, respectively, and γ̂3 is the spillover effect estimator for unit 3. Tests can
be performed accordingly. If one wants to test for the hypothesis that there are no spillover effects, the
null is then H0 : Cα = d, where C = (0, 0, 1, 0) and d = 0.
4.2 Multiple post-treatment time periods
Suppose now we have observations of {yi,t} for i = 1, . . . , N and t = 1, . . . , T +m. Treatment is received
at t = T + 1. The model becomes
Yt =

Yt(0), if t ≤ T
Yt(0) + αt, otherwise.
Note that we do not allow for spillovers in time. That is, the treatment effect or spillover effects cannot
affect future selves. For each t = T + 1, . . . , T +m, we need to specify the spillover structure matrix At.
Then, an estimator of αt is
α̂t = At(A
′
tM̂At)
−1A′t(I − B̂)′((I − B̂)Yt − â).
That is, we treat T+s period as T+1 and do the same procedure as before. For each t = T+1, . . . , T+m,
we can perform separate tests as introduced in previous sections.
To answer simultaneous questions such as whether there is spillover effect at all, we can extend the
P -test discussed above. Consider the null hypothesis H0 : Ctαt = dt for t = T + 1, . . . , T +m. Let P̂t be
constructed as in Section 3.2 for t = 1, . . . , T . For t = T+1, . . . , T+m, let P̂t = (Ctα̂t−dt)′WT (Ctα̂t−dt).
We can now form
P (t) =
m−1∑
s=0
P̂t+s
for t = 1, . . . , T + 1. The test statistic is then P (T+1), and we use {P (t)}Tt=1 to form its null distribution.
4.3 Including covariates
Many empirical researchers are interested including extra covariates when using synthetic control meth-
ods. Our framework can be readily adapted to settings with covaraites. Suppose we have a vector of
observable variables zi,t and want to estimate the treatment effects, while being worried about spillover
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effects. Following Li (2019), we estimate the least square coefficients for the model
yi,t(0) = ai +
∑
j 6=i
bi,jyj,t(0) + z
′
i,tpi + ui,t,
with the simplex constraints on bi,j and obtain coefficient estimates (âi, b̂i, pii). This is done for each i.
Let ĝt = (z
′
1,tpii, . . . , z
′
N,tpiN )
′. Under appropriate regularity conditions, the results of the paper apply
when the intercept estimator â is replaced by â + ĝt at time t. For example, the treatment effects
estimator now becomes
γ̂ = (A′M̂A)−1A′(I − B̂)′((I − B̂)YT+1 − â− ĝT+1).
5 Simulation
We present Monte Carlo simulation results in this section. For each case considered, we use 1000 simu-
lation repetitions.
5.1 Estimation with spillover effects
In this subsection we examine the finite sample performance of our estimation procedure proposed in
Section 2.2. The model considered here is similar to Li (2019), where yi,t(0) follows a factor model
structure. We show both stationary and I(1) case.
5.1.1 Stationary case
The underlying factor model is
yi,t(0) = ηt + λ
′
tµi + i,t,
where λt = (λ1,t, λ2,t, λ3,t)
′,
ηt = 1 + 0.5δt−1 + ν0,t,
λ1,t = 0.5λ1,t−1 + ν1,t,
λ2,t = 1 + ν2,t + 0.5ν2,t−1,
λ3,t = 0.5λ3,t−1 + ν3,t + 0.5ν3,t−1,
and i,t and νj,s is i.i.d. N(0, 1) for each (i, j, s, t). Each entry of µi is drawn from an independent
uniform distribution on [0, 1] and fixed for each repetition. At t = T + 1, the observed outcome is
yi,T+1 = yi,T+1(0) +αi, where αi is either treatment effect or spillover effect and is specified below. The
treatment effect is set to 5 and the spillover effect is 3.
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Table 1: Treatment effect estimation with stationary common factors.
N = 10 N = 30 N = 50
T = 15 50 200 15 50 200 15 50 200
No spillover effects
SCM -0.062 0.011 -0.003 0.114 -0.005 0.016 0.037 -0.041 -0.033
(2.113) (1.249) (1.586) (1.642) (1.244) (1.273) (1.408) (1.290) (1.182)
SP -0.077 0.013 0.018 0.091 -0.012 0.010 0.042 -0.031 -0.040
(2.618) (1.417) (1.710) (1.974) (1.362) (1.486) (1.741) (1.516) (1.270)
Concentrated spillover effects
SCM -1.326 -0.986 -1.333 -0.756 -0.880 -1.543 -1.492 -1.070 -0.796
(2.714) (1.451) (2.065) (1.958) (1.654) (1.392) (1.912) (1.638) (1.461)
SP 0.267 0.025 0.140 0.248 0.038 0.025 -0.133 -0.055 0.110
(2.554) (1.425) (1.756) (1.897) (1.435) (1.250) (1.700) (1.581 ) (1.408)
Spreadout spillover effects
SCM -2.378 -1.910 -2.114 -2.245 -1.859 -2.398 -2.147 -2.112 -2.154
(2.493) (1.470) (1.696) (2.029) (1.472) (1.369) (1.791) (1.538) (1.313)
SP -0.048 0.007 0.029 0.090 -0.025 0.018 0.037 -0.048 -0.028
(2.740) (1.438) (2.061) (2.231) (1.296) (1.602) (1.643) (1.450) (1.290)
Notes: The numbers without parentheses are empirical bias in simulation. The ones with parentheses are
empirical variance. SCM is the standard synthetic control method assuming no spillover effects. SP is the
estimation procedure proposed in this paper that takes spillover effects into account. No spillover effects
stands for the cases where the true DGP has no spillover effects. Concentrated spillover effects is the case
where 1/3 of the control units receive a spillover effect. Spreadout spillover effects is the case where 2/3 of the
control units receive a spillover effect of the same level.
The empirical bias and variance (in parentheses) of the treatment effect estimator using two methods
are shown in Table 1. We consider three spillover patterns. No spillover effects is the case where unit
1 receives a treatment effect of 5 at t = T + 1 and other units are not affected. Concentrated spillover
effects is the case where 1/3 of the control units receive a spillover effect of 3. Spreadout spillover effects
is the case where 2/3 of the control units receive a spillover effect of 3. SCM is the original synthetic
control method, and SP is the corrected synthetic control method proposed in Section 2.3. Throughout
the simulations we assume the coverage of spillover effect is known, but not other information, so A is
constructed as in Example 3. For No spillover effects, we are being conservative in our use of the SP
estimator and run it as if 1/3 of the control units are exposed to spillover effects.
To better compare results, we fit the simulation results using kernel density for the (N,T ) = (10, 50)
case with concentrated spillover effects and plot it in Figure 4.
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Figure 4: Distribution of treatment effect estimates. The true treatment effect is 5. SCM is using the standard
synthetic control method assuming no spillover effects. SP is the estimation procedure proposed in this paper that
takes spillover effects into account. Estimates are fitted using kernel density.
5.1.2 I(1) case
For the I(1) case, the underlying factor model follows
yi,t(0) = λ
′
tµi + i,t,
where λt = (λ1,t, λ2,t, λ3,t)
′,
λ1,t = λ1,t−1 + 0.5ν1,t,
λ2,t = λ2,t−1 + 0.5ν2,t,
λ3,t = 0.5λ3,t−1 + ν3,t,
and i,t and νj,s follows i.i.d. N(0, 1) for each (i, j, s, t). The factor loadings are constructed such that
condition CO is satisfied. Namely, we let µ1 = (1, 0, 0)
′, µ2 = (0, 1, 0)′, µ3 = (1, 0, 0)′, µ4 = (0, 1, 0)′,
and for µj with j = 5, . . . , N , we draw independent uniform distribution on [0, 1] for each entry and then
normalize each loading vector such that three entries of each µj sum up to one. The constructed factor
loadings are fixed for each repetition while other settings are same as the stationary case. The results
are shown in Table 2.
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Table 2: Treatment effect estimation with I(1) common factors.
N = 10 N = 30 N = 50
T = 15 50 200 15 50 200 15 50 200
No spillover effects
SCM -0.023 -0.018 -0.043 0.036 -0.088 -0.031 0.041 0.038 -0.038
(1.873) (1.642) (1.772) (1.708) (1.539) (1.900) (1.915) (1.810) (1.866)
SP -0.021 -0.057 -0.017 0.037 -0.053 -0.044 0.007 0.013 -0.017
(2.460) (2.249) (4.523) (2.116) (2.121) (2.184) (2.308) (1.849) (1.952)
Concentrated spillover effects
SCM -1.185 -1.400 -2.234 -1.206 -2.026 -1.954 -1.316 -1.408 -2.325
(2.421) (1.854) (1.856) (2.269) (1.921) (2.079) (2.449) (2.043) (1.976)
SP -0.021 -0.057 -0.017 0.037 -0.053 -0.044 0.007 0.013 -0.017
(2.460) (2.249) (4.523) (2.116) (2.121) (2.184) (2.308) (1.849) (1.952)
Spreadout spillover effects
SCM -2.088 -2.599 -2.885 -2.233 -2.536 -2.465 -2.219 -2.402 -2.889
(2.390) (1.779) (1.795) (2.101) (1.759) (2.037) (2.249) (1.921) (1.900)
SP -0.029 0.027 -0.022 0.047 -0.008 0.010 0.022 0.006 -0.045
(2.452) (3.447) (7.367) (2.357) (2.412) (2.740) (2.418) (2.279) (2.712)
Notes: The numbers without parentheses are empirical bias in simulation. The ones with parentheses are
empirical variance. SCM is the standard synthetic control method assuming no spillover effects. SP is the
estimation procedure proposed in this paper that takes spillover effects into account. No spillover effects
stands for the cases where the true DGP has no spillover effects. Concentrated spillover effects is the case
where 1/3 of the control units receive a spillover effect. Spreadout spillover effects is the case where 2/3 of the
control units receive a spillover effect of the same level.
5.2 Test for treatment effects
In this section we compare test procedures against the null hypothesis H0 : α1 = 0, i.e. the treatment
effect is zero. The results are shown in Table 3 and Table 4. The DGP is exactly the same as in Section
5.1.1 (the stationary case), except that α1 = 0 (the null) for Table 3 and α1 = 5 (the alternative) for
Table 4. Placebo test is as in Abadie and Gardeazabal (2003) and Hahn and Shi (2017). Andrews’ test
is as in Andrews (2003). SP is the spillover-adjust test proposed in Section 3.2.
Among the three testing procedures, SP test has correct sizes and outperforms the other two methods
in power. Placebo test has correct sizes in some cases but has lower power, and Andrews’ test over-rejects
under null. The reasons are discussed in Section 3.3.
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Table 3: Empirical rejection rate of testing for treatment effects under null.
N = 10 N = 30 N = 50
T = 15 50 200 15 50 200 15 50 200
No spillover effects
Placebo 0.000 0.000 0.000 0.072 0.053 0.062 0.034 0.031 0.040
Andrews 0.076 0.061 0.060 0.108 0.082 0.065 0.141 0.078 0.072
SP 0.048 0.049 0.058 0.055 0.064 0.052 0.066 0.046 0.059
Concentrated spillover effects
Placebo 0.000 0.000 0.000 0.066 0.046 0.116 0.035 0.029 0.026
Andrews 0.411 0.207 0.224 0.417 0.279 0.346 0.519 0.346 0.184
SP 0.065 0.050 0.043 0.111 0.069 0.061 0.109 0.092 0.054
Spreadout spillover effects
Placebo 0.000 0.000 0.000 0.129 0.063 0.147 0.060 0.059 0.072
Andrews 0.576 0.478 0.399 0.685 0.563 0.616 0.741 0.621 0.544
SP 0.036 0.035 0.042 0.034 0.042 0.046 0.030 0.042 0.044
Notes: SP is the estimation procedure proposed in this paper that takes spillover effects into
account. No spillover effects stands for the cases where the true DGP has no spillover effects.
Concentrated spillover effects is the case where 1/3 of the control units receive a spillover effect.
Spreadout spillover effects is the case where 2/3 of the control units receive a spillover effect of the
same level.
5.3 Test for existence of spillover effects
In this section we examine the power of the proposed test against the null hypothesis that there are no
spillover effects. We also look into its behavior when the range of the spillover effect is not correctly
specified. In this set of experiments, the level of spillover effects varies from 0 to 2, corresponding to
the strength of alternative hypotheses. We set (N,T ) = (20, 50) and α1 = 5. There are 9 units that are
affected by spillover effects. Other settings follow exactly as in Section 5.1.1 (the stationary case). The
model for the range of spillover is as in Example 3.
The empirical rejection rates against various levels of spillover effects using our method proposed in
Section 3.2 are plotted in Figure 5. Here Include too few misses half of the units that are actually affected
by the treatment (assuming that unit 1 as well as four other units are affected), Correct specification
assumes we know exactly which units are affected, and Include too many assumes 15 units are affected
in estimation, 5 of which are actually not affected by spillover effects.
The simulation results show that the proposed test is quite robust to model misspecification. Among
the three cases, Include too many is still a correct specification but is supposed to be more conservative,
so it has less power than Correct specification does. The range of spillover effects is misspecified in Include
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Table 4: Empirical rejection rate of testing for treatment effects under alternative.
N = 10 N = 30 N = 50
T = 15 50 200 15 50 200 15 50 200
No spillover effects
Placebo 0.000 0.000 0.000 0.908 0.939 0.966 0.922 0.936 0.931
Andrews 0.797 0.948 0.926 0.785 0.901 0.983 0.797 0.972 0.827
SP 0.835 0.956 0.923 0.823 0.937 0.965 0.839 0.964 0.993
Concentrated spillover effects
Placebo 0.000 0.000 0.000 0.461 0.502 0.448 0.465 0.434 0.464
Andrews 0.651 0.765 0.329 0.704 0.754 0.542 0.680 0.746 0.737
SP 0.860 0.932 0.991 0.957 0.918 0.967 0.834 0.816 0.853
Spreadout spillover effects
Placebo 0.000 0.000 0.000 0.348 0.378 0.331 0.305 0.255 0.294
Andrews 0.337 0.403 0.277 0.563 0.414 0.278 0.406 0.309 0.343
SP 0.866 0.978 0.981 0.969 0.950 0.991 0.909 0.985 0.974
Notes: SP is the estimation procedure proposed in this paper that takes spillover effects into
account. No spillover effects stands for the cases where the true DGP has no spillover effects.
Concentrated spillover effects is the case where 1/3 of the control units receive a spillover effect.
Spreadout spillover effects is the case where 2/3 of the control units receive a spillover effect of the
same level.
too few, but the test is still correctly sized under the null4 and has reasonable power under alternatives.
6 Empirical Example
To demonstrate our method, we use it on the classic SCM example from Abadie et al. (2010) (ADH),
which looks at the effect of Proposition 99 on California cigarette consumption. In this section, we will
walk through the results from our method, with interruptions to point out key features and issues.
Proposition 99 intended to disincentivize smoking, which was primarily achieved by introducing a
$0.25 tax on each pack of cigarettes. By measuring sales in California, ADH and others have attempted
to determine the effect of the policy on smoking rates. However, traditional SCM is not guaranteed to
produce an unbiased treatment effect estimator in the presence of spillover effects. In this tobacco control
program example, we are concerned about two kinds of spillover effects. The first spillover is based on
concerns about “leakage”. A common problem with cigarette taxes is that measured local consumption
might fall as people move their purchasing behavior across legal boundaries. In order to accommodate
this, we allowed for a spillover affecting states neighboring California and a spillover affecting states
4The model is always correctly specified under null.
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Figure 5: Empirical rejection rate of testing for existence of spillover effects. There are 20 units in total and half
of them are affected by the treatment. Include too few is assuming only 5 of them are affected by the treatment.
Correct specification assumes the researcher knows exactly which set of units are affected. Include too many assumes
15 units are affected, 5 of which are in fact not affected.
which a state away from California. The second spillover type we considered was a cultural change. If
tobacco is discouraged in California, it might reduce the cultural appeal of smoking. Reasoning that the
northeast is culturally close to the west coast, we allowed for the northeastern states to experience this
cultural spillover.
One might also think that there could be a policy contamination whereby culturally close states also
enact policies with similar targets. Our method can allow for this kind of spillover in our estimation.
However, the initial paper took that type of problem into account, and 12 states which experienced
legislative changes in the ensuing years were removed in that paper (and thus in our data).
The data used is per capita cigarette consumption in 38 of the 50 states running from 1970 to 2000.
Twelve states were removed from the data because of concerns that they were either contaminated,
or received treatment later on. In 1989 California enacted Proposition 99, so all periods from 1989
onwards are considered post-treatment periods. We replicate this program evaluation using the method
introduced in previous sections, allowing for possible spillover effects. We use the spillover structure as
in Example 3. That is, we allow for arbitrary spillover effects in those geographically close and culturally
similar states as described in the last paragraph, but not the others. We also perform hypothesis testing
on both treatment effects and spillover effects.
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Figure 6: Trends in per-capita cigarette sales: California, synthetic California, and spillover-adjusted synthetic
California. SP synthetic California is using our estimation procedure, which accounts for spillover effects. The
vertical line indicates the start of treatment.
The results are shown in Figure 6 and Figure 7. The method in Abadie et al. (2010) is indexed by
SCM and our method is SP. Figure 6 shows the “synthetic California” and Figure 7 elaborates on this
by specifically looking at the estimated treatment effects. The error bars are built using the methods
described in this paper, at a significance level of 90%. We do not use a 95% significance level because
there are only 19 pre-treatment periods.
As Figure 6 shows, our estimated consumption in the “synthetic California” does not differ qualita-
tively from what a standard SCM would predict. Quantitatively, Figure 7 shows that our results are more
consistent with an addiction story, that tobacco consumption is addictive and should not fall immediately
after the policy. From the tests of spillover effects (shaded area of Figure 7), we see that likely there
were substantial spillover effects, which in some periods lead to statistically significant changes in the
treatment effect estimates. For example, the SCM estimate of year 1990 lies outside our confidence in-
terval, which potentially results from the over-estimation of scale of the treatment effects in the presence
of spillover effects.
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Figure 7: Per-capita cigarette sales gap between California and (spillover-adjusted) synthetic California (with 90%
confidence interval). The lines to the right of passage of Proposition 99 are treatment effect estimates. SCM is
obtained by using standard synthetic control method. SP is using our estimation procedure, which accounts for
spillover effects. Shaded area denotes our test rejects there is no spillover effects in those years.
7 Conclusion
The synthetic control method is a powerful tool in treatment effect estimation in the panel data settings,
but it does not work in the presence of spillover effects. In this paper, we relax this assumption and
propose an estimation and testing procedure that is robust to the presence of spillover effects. Our
method requires specification of the spillover structure, which can be weak (Example 3). We derive a set
of conditions under which our estimators are asymptotically unbiased. We develop a testing procedure
based on Andrews (2003)’s end-of-sample instability tests and show that it is asymptotically unbiased
under a set of conditions. We show our conditions are satisfied by the commonly used factor models, with
either stationary or cointegrated common factors. Our methods can be extended to cases with multiple
treated units and multiple post-treatment periods, and with extra covariates. Simulation results certify
the validity of our estimation and testing procedure in the presence of spillover effects. The simulations
also indicate that our testing procedure is relatively robust to misspecification of the spillover structure.
Finally, we illustrate our method by applying it to Abadie et al. (2010)’s California tobacco control
program data.
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Appendix
Proof of Lemma 1. (i) First assume Condition IN and Condition ST holds. The proof follows Ferman
and Pinto (2019), except that we do not assume that there is a set of weights that reconstruct the factor
loadings and belong to the simplex.
We first show part (b). It suffices to show |âi − ai| = op(1) and ‖b̂i − bi‖ = op(1) for each i, i.e. ai
and bi are well-defined. We show it for the i = 1 case and other cases follow the same strategy. Let
y¯j = T
−1∑T
t=1 yj,t. Write down an (equivalent) optimization problem
v̂ = arg min
v∈V
(
(y1,t − y¯1)−
N∑
j=2
(yj,t − y¯j)vj
)2
,
where V = {v = (v2, . . . , vN ) ∈ RN−1+ :
∑N
j=2 vj = 1}. The objective is strictly convex (with probability
approaching one), so the solution is unique. Note that it implies b̂1 is numerically equivalent to (0, v̂
′)′,
otherwise the minimization problem in forming â1 and b̂1 may have a lower objective evaluated at
(y¯1 −∑Nj=2 y¯j v̂j , 0, v̂′)′. Now we let Q̂(v) denote the objective function such that
Q̂(v) =
1
T
T∑
t=1
(
(y1,t − y¯1)−
N∑
j=2
(yj,t − y¯j)vj
)2
,
and its population analog be
Q(v) =
−1
v

′
Ωy
−1
v
 .
Let v0 be a minimizer of Q(v) in V . We verify the conditions for consistency (see Newey and McFadden,
1994, Theorem 2.1) : (i) Since Ωy is positive definite, Q(v) is strictly convex. Also, V is convex. Therefore,
Q(v) is uniquely minimized at v0. (ii) V is compact, since it is a (N − 1)-dimensional simplex. (iii) Q(v)
is continuous, since it has a quadratic form. (iv) To see uniform convergence, note
sup
v∈V
|Q̂(v)−Q(v)| = sup
v∈V
∣∣∣∣∣∣∣
−1
v

′(
1
T
T∑
t=1
(Yt − Y¯ )(Yt − Y¯ )′ − Ωy
)−1
v

∣∣∣∣∣∣∣
≤ sup
v∈V
∥∥∥∥∥∥∥
−1
v

∥∥∥∥∥∥∥
2 ∥∥∥∥∥ 1T
T∑
t=1
(Yt − Y¯ )(Yt − Y¯ )′ − Ωy
∥∥∥∥∥
F
≤ N · op(1)
= op(1),
where ‖ · ‖F is the Frobenius norm. The second inequality is by ergodicity for the second moments.
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Therefore, v̂ →p v0. This implies ‖b̂1 − b1‖ = op(1). By ergodicity,
â1 = y¯1 − [y¯2 y¯3 . . . y¯N ]v̂ →p E[y1,t(0)− Yt(0)′b1] = a1.
This shows part (b) and E[u1,t] = 0 by definition of ui,t. We also have that {ut}t≥1 is stationary since
it is a linear combination of stationary and ergodic processes. This shows part (a) in Assumption 1.
Part (c) follows from part (b) and the stationarity of {YT+1(0)}T≥1. Part (d) follows by Condition
IN. Thus, Assumption 1 holds under Condition IN and Condition ST.
(ii) Now we instead assume Condition IN and Condition CO holds.
We first show part (c). We will show ‖YT+1(0)′(̂b1 − b1)‖ = op(1) and other i’s follows the same
strategy. Since the synthetic control estimator can be written as a projection of the OLS estimator onto
a closed convex set, we will first derive the asymptotic properties of the OLS estimator, and then use the
properties of projections to obtain the desired results. For examples of this strategy, see Li (2019) and
Yu et al. (2019). For some positive definite matrix D ∈ RN , let RN be a Hilbert space with the inner
product 〈·, ·〉D such that for θ1, θ2 ∈ RN ,
〈θ1, θ2〉D = θ′1Dθ2.
The norm ‖ · ‖D is defined accordingly, i.e. ‖θ‖D =
√
θ′Dθ, for θ ∈ RN . For a closed convex set Λ ⊂ RN ,
define a projection ΠD such that for each θ ∈ RN , ΠDθ = arg minθ′∈Λ ‖θ − θ′‖D. Zarantonello (1971)
shows that for each θ, θ′ ∈ RN ,
‖ΠDθ −ΠDθ′‖D ≤ ‖θ − θ′‖D. (8)
With some abuse of notation, let xt = Yt − T−1∑Ts=1 Ys. Then, b̂1 is the synthetic control weight
estimators of regressing (y1,t − T−1∑Ts=1 y1,s) on xt, subject to {0} × ∆N−1 with ∆N−1 being an
(N − 1)-dimensional simplex. Let b˜1 be the OLS estimator of regressing (y1,t − T−1∑Ts=1 y1,s) on xt.
Let ΣT = T
−1∑T
t=1 xtx
′
t.
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Appendix A.2 in Li (2019) establishes that b̂1 = ΠΣT b˜1. Thus, we have
‖b̂1 − b1‖ = ‖Σ−1/2T Σ1/2T (̂b1 − b1)‖
≤ ‖Σ−1/2T ‖F · ‖Σ1/2T (̂b1 − b1)‖
= ‖Σ−1/2T ‖F · ‖b̂1 − b1‖ΣT
= ‖Σ−1/2T ‖F · ‖ΠΣT b˜1 −ΠΣT b1‖ΣT
≤ ‖Σ−1/2T ‖F · ‖b˜1 − b1‖ΣT
= ‖Σ−1/2T ‖F · ‖Σ1/2T ‖F · ‖b˜1 − b1‖
= Op(1)op(T
−1/2)
= op(T
−1/2), (9)
where ‖ · ‖F is the Frobenius norm of a matrix. The third equality is because b1 ∈ {0} × ∆N−1. The
second inequality is by (8). To see the fifth equality, note
ΣT = T
(
1
T 2
T∑
t=1
YtY
′
t −
(
1
T 3/2
∑
t=1
Yt
)(
1
T 3/2
∑
t=1
Yt
)′)
,
so
‖Σ−1/2T ‖F · ‖Σ1/2T ‖F = tr(Σ−1T )tr(ΣT ) = Op(1) ·
1
T
· T ·Op(1) = Op(1),
where the second equality is standard results for I1 process (see Hamilton, 1994, part (g) and (i) of
Proposition 18.1). Also, ‖b˜1 − b1‖ = op(T−1/2) is by Proposition 19.2 in Hamilton (1994). This shows
(9). Apply part (a) of Proposition 18.1 in Hamilton (1994), we have
‖YT+1(0)′(̂b1 − b)‖ = ‖(T−1/2YT+1(0))′(T−1/2(̂b1 − b))‖ = Op(1)op(1) = op(1).
Now we show part (b). Again, it suffices to show |âi− ai| = op(1) and ‖b̂i− bi‖ = op(1). We consider
the i = 1 case and other cases follow the same strategy. We have showed ‖b̂i − bi‖ = op(1) in part (c) of
the proof. Section A.6.1 in Ferman and Pinto (2019) establishes that
[µ11 µ
1
2 . . . µ
1
N ](b1 − e1) = 0, (10)
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where ei is the unit vector with one at the i-th entry. Thus,
â1 = [y¯1 y¯2 . . . y¯N ](e1 − b̂1)
= [y¯1 y¯2 . . . y¯N ](e1 − b1) + [y¯1 y¯2 . . . y¯N ](b1 − b̂1)
=
{
1
T
T∑
t=1
(
(λ0t )
′[µ01 . . . µ
0
N ] + [1,t . . . N,t]
)}
(e1 − b1) +
(
1√
T
[y¯1 y¯2 . . . y¯N ]
)√
T (b1 − b̂1)
= E[λ0t ]
′[µ01 . . . µ
0
N ](e1 − b1) + op(1) +Op(1)op(1)
→p E[λ0t ]′[µ01 . . . µ0N ](e1 − b1).
= a1 (11)
The third equality is by (10). The fourth equality is by stationarity of {(λ0t , t)}t≥1 and results in part
(d) of the proof. This shows part (b) of the Assumption 1 .
Combining (10) and (11), we have part (a) in Assumption 1. Part (d) is assumed by Condition
IN.
Proof of Theorem 1. Using formula of γ̂ in Equation (6), we have
γ̂ = (A′M̂A)−1A′(I − B̂)′((I − B̂)YT+1(0) + (I − B̂)α− â)
= (A′M̂A)−1A′(I − B̂)′(uT+1 + (B − B̂)YT+1(0) + (a− â) + (I − B̂)Aγ)
= (A′M̂A)−1A′(I − B̂)′uT+1 + op(1) + op(1) + γ.
The first equality is by YT+1 = YT+1(0) +α. The second equation is because YT+1(0) = a+BYT+1(0) +
uT+1. The third equation is by (b) and (c) in Assumption 1. Therefore,
α̂− (α+GuT+1) = A(A′M̂A)−1A′(I − B̂)′uT+1 +Aγ + op(1)− α−GuT+1
= (A(A′M̂A)−1A′(I − B̂)−G)′uT+1 + op(1)
= op(1)Op(1) + op(1)
= op(1).
The third equality is by (b) in Assumption 1 and stationarity of {ut}t≥1.
Proof of Proposition 1. The proof for the first half of the proposition is similar to the proof for
Theorem 1, and thus is omitted. Too see the second half, note
Cov[GWuT+1] = A(Q
′WQ)−1Q′WΩWQ(Q′WQ)−1A′
and
Cov[GeuT+1] = A(Q
′ΩQ)−1A′,
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where Q = (I − B)A. It suffices to show ((Q′WQ)−1Q′WΩWQ(Q′WQ)−1 − (Q′ΩQ)−1) is positive
semi-definite. Note that the first term is asymptotic variance of using W as the weighting matrix in
GMM exercise and the second term is the one using the efficient weighting matrix (see Hayashi, 2000,
Proposition 3.5). Thus, (Cov[GWuT+1]− Cov[GeuT+1]) is positive semi-definite.
Proof of Lemma 2. Since Assumption 3 implies Assumption 2, we only need to show Lemma 3.
Proof of Theorem 2. We follow the proof of Theorem 2 in Andrews and Kim (2006). Let
L1,T () =
{
‖CT (β̂1 − β1)‖ ≤ , max
t=1,...,T
‖CT (β̂(t)1 − β1)‖ ≤ 
}
,
L2,T (c) =
{
max
t≤T+1
‖C−1T xt‖ ≤ c
}
.
By Assumption 2(d), there exists a positive sequence {T }T≥1 such that T → 0 and Pr(L1,T (T ))→ 1.
Let cT = 1/
√
T . So we have cT →∞ and cT T → 0. By Assumption 2(c), we must have Pr(L2,T (cT ))→
1. Let LT = L1,T (T ) ∩ L2,T (cT ), then we have Pr(LT )→ 1 and Pr(LcT )→ 0.
Suppose LT holds. Then, for β = β̂1 or β = β̂
(t)
1 for some t = 1, . . . , T , we have
|Pt(β)− Pt(β1)| =
∣∣(β − β1)′xtx′t(β − β1)− 2x′t(β − β1)u1,t∣∣
=
∣∣(β − β1)′C′T (C′T )−1xtx′tC−1T CT (β − β1)− 2x′tC−1T CT (β − β1)u1,t∣∣
≤ ‖CT (β − β1)‖2‖C−1T xt‖2 + 2‖C−1T xt‖‖CT (β − β1)‖|u1,t|
≤ 2T c2T + 2T cT |u1,t|.
Define gt(T , cT ) = 
2
T c
2
T + 2T cT |u1,t|. Note that gt(T , cT ) is identically distributed across t for a fixed
T , by Assumption 2(a).
We first prove part (a). Let x be some continuous point of distribution function of PT+1(β1). Then,
Pr(PT+1(β̂1) ≤ x) = Pr({PT+1(β̂1) ≤ x} ∩ LT ) + Pr({PT+1(β̂1) ≤ x} ∩ LcT )
≤ Pr(PT+1(β̂1) ≤ x+ gt(T , cT )) + Pr(LcT )
≤ Pr(PT+1(β1) ≤ x) + o(1).
To see the last equality, pick  > 0. By continuity, ∃δ > 0 such that for each y ∈ (x − δ, x + δ),
|Pr(PT+1(β1) ≤ y)− Pr(PT+1(β1) ≤ x)| < . Therefore,
Pr(PT+1(β̂1) ≤ x+ gt(T , cT )) = Pr({PT+1(β̂1) ≤ x+ gt(T , cT )} ∩ {|gt(T , cT )| ≥ δ})
+ Pr({PT+1(β̂1) ≤ x+ gt(T , cT )} ∩ {|gt(T , cT )| < δ})
≤ Pr(|gt(T , cT )| ≥ δ) + Pr(PT+1(β̂1) ≤ y)
< Pr(PT+1(β1) ≤ x) + o(1).
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Similarly,
Pr(PT+1(β̂1) ≤ x) ≥ Pr(PT+1(β1) ≤ x) + o(1).
This shows part (a).
To see part (b), let k : R → R be a monotonically decreasing and everywhere differentiable function
that has bounded derivative and satisfies k(x) = 1 for x ≤ 0, k(x) ∈ [0, 1] for x ∈ (0, 1), and k(x) = 0 for
x ≥ 1. For example, let k(x) = cos(pix)/2 + 1/2 for x ∈ (0, 1). Given some {β(t)}Tt=1, a smoothed df is
defined by
F̂T (x, {βt}, hT ) = 1
T
T∑
t=1
k
(
Pt(β
(t))− x
hT
)
,
for some sequence of positive constants {hT } such that hT → 0 and cT T /hT → 0. For example, we let
hT = 
1/4
T when cT = 1/
√
T . Also, define,
F̂T (x, {β1}) = 1
T
T∑
t=1
1{Pt(β1) ≤ x},
i.e., F̂T (x, {β1}) is the empirical cdf of Pt as if the true parameter β1 is known.
We write
|F̂P,T (x)− FP (x)| ≤
4∑
i=1
Di,T ,
for
D1,T = |F̂P,T (x)− F̂T (x, {β̂j}, hT )|,
D2,T = |F̂T (x, {β̂j}, hT )− F̂T (x, {β1}, hT )|,
D3,T = |F̂T (x, {β1}, hT )− F̂T (x, {β1})|, and
D4,T = |F̂T (x, {β1})− FP (x)|.
We want to show that all four terms vanish. First note that
D1,T ≤ 1
T
T∑
t=1
1
{
Pt(β̂
(t)
1 )− x
hT
∈ (0, 1)
}
.
Thus, for any δ > 0,
Pr(D1,T > δ) ≤ Pr({D1,T > δ} ∩ LT ) + Pr(LcT )
≤ Pr
(
1
T
T∑
t=1
1
{
Pt(β̂
(t)
1 )− x ∈ (−gt(T , cT ), hT + gt(T , cT )
}
> δ
)
+ o(1)
≤
E1
{
Pt(β̂
(t)
1 )− x ∈ (−gt(T , cT ), hT + gt(T , cT )
}
δ
+ o(1), (12)
where the last inequality is by Markov’s inequality. Recall Pr(P1(β1) 6= x) = 1 and gt(T , cT ) → 0 a.s.,
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so 1{Pt(β1)− x ∈ {−gt(T , cT ), hT + gt(T , cT )} → 0 a.s.. By the dominated convergence theorem, (12)
implies Pr(D1,T > δ) ≤ o(1) and thus D1,T = op(1).
For D2,T , we have
D2,T =
∣∣∣∣∣ 1T
T∑
t=1
k′
(
P˜t − x
hT
)
Pt(β̂
(t)
1 )− Pt(β1)
hT
∣∣∣∣∣
≤ k¯
T
T∑
t=1
gt(T , cT )
hT
.
The equality is by the mean value theorem and we have P˜t lies between Pt(β̂
(t)
1 ) and Pt(β1). In the
inequality, k¯ is a bound for the derivative of k. Also, note
E
[
gt(T , cT )
hT
]
=
2T c
2
T
hT
+ 2
T cT
hT
E|u1,t| = o(1).
Therefore,
Pr(D2,T > δ) ≤ Pr({D2,T > δ} ∩ LT ) + Pr(LcT )
≤ Pr
(
k¯
T
T∑
t=1
gt(T , cT )
hT
> δ
)
+ o(1)
≤ k¯ Egt(T , cT )
δhT
→ 0.
The third inequality is by Markov’s inequality. This shows D2,T = op(1).
D3,T is similar to the D1,T case. Finally, by stationary and ergodicity of u1,t, we have D4,T = op(1).
This shows part (b).
Now we show part (c). Pick any small  such that F̂P,T (x)→p FP (x) for x ∈ (qP,1−τ − , qP,1−τ + ).
Note
Pr(q̂P,1−τ > qP,1−τ + ) ≤ Pr(F̂P,T (qP,1−τ + ) < 1− τ)
= Pr(F̂P,T (qP,1−τ + )− FP (qP,1−τ + ) < (1− τ)− FP (qP,1−τ + ))
→ 0.
The inequality is by definition of q̂P,1−τ . The convergence is because of part (e) of Assumption 2 and
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part (b) of Theorem 2. Similarly,
Pr(q̂P,1−τ < qP,1−τ − ) ≤ Pr(F̂P,T (qP,1−τ − ) ≥ 1− τ)
= Pr(F̂P,T (qP,1−τ − )− FP (qP,1−τ − ) ≥ (1− τ)− FP (qP,1−τ − ))
→ 0.
Again, the inequality is by definition of q̂P,1−τ , and the convergence is because of part (e) of Assumption
2 and part (b) of Theorem 2.
Finally, we show part (d). Under null, P∞ and P1(β1) have the same distribution, so qP,1−τ is
(1− τ)-quantile of P∞. Therefore,
Pr(P > q̂P,1−τ ) = 1− Pr(P ≤ q̂P,1−τ )
= 1− Pr(P + (qP,1−τ − q̂P,1−τ ) ≤ qP,1−τ )
→ τ,
where the convergence is by combining part (a) and (c). This concludes our proof.
Proof of Lemma 3. (i) Assume Condition ST holds.
By Lemma 1, part (a) of Assumption 3 holds.
Part (b) is because ut is a linear combination of ηt, λt, t.
For part (c), pick some τ such that 1/(2 + δ) < τ < 1/2, where δ is defined in Condition ST. Let
DT =
1 0
0 T τIN
 . (13)
Then, we have
max
t≤T+1
‖D−1T xt‖ = max
t≤T+1
∥∥∥∥∥∥∥
 1
T−τYt

∥∥∥∥∥∥∥ =
√
1 +
(
max
t≤T+1
‖T−τYt‖
)2
. (14)
Also, for any  > 0, note
Pr
(
max
t≤T+1
‖T−τYt‖ > 
)
= Pr
 ⋃
t≤T+1
‖Yt‖ > T τ 

≤
(
T∑
t=1
Pr(‖Yt‖ > T τ )
)
+ Pr(‖YT+1(0) + α‖ > T τ )
=
TE[‖Yt‖2+δ]
T τ(2+δ)2+δ
+ o(1)
= o(1). (15)
The second equality is due to Markov inequality and stationarity of {YT+1(0)}t+1. The last equality is
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because τ > 1/(2 + δ). Combining (14) and (15), we obtain part (c).
For part (d), we use DT defined in (13). Following the same reasoning as in (9), for each i = 1, . . . , N ,
we have
‖b̂i − bi‖ ≤ ‖Σ−1/2T ‖F · ‖Σ1/2T ‖F · ‖b˜i − bi‖
= Op(1)Op(T
−1/2)
= Op(T
−1/2). (16)
The first equality is because {Yt(0)}t≥1 is ergodic for the second moment, and b˜i is the OLS estimator
for bi. Thus,
‖DT (β̂i − βi)‖ =
∥∥∥∥∥∥∥
1 0
0 T τ−1/2IN

1 0
0 T 1/2IN
 (β̂i − βi)
∥∥∥∥∥∥∥
≤
∥∥∥∥∥∥∥
1 0
0 T τ−1/2IN

∥∥∥∥∥∥∥
F
∥∥∥∥∥∥∥
 âi − ai√
T (̂bi − bi)

∥∥∥∥∥∥∥
=
√
1 +NT 2τ−1‖Op(1)‖
= op(1).
The second equality is due to (16). The last equality is because τ < 1/2. Therefore,
‖(θ̂ − θ0)DT ‖F =
√√√√ N∑
i=1
‖DT (β̂i − βi)‖2 = op(1).
Also, since θ̂(t) = θ̂ for each t,
max
t=1,...,T
‖(θ̂(t) − θ0)DT ‖F = ‖(θ̂ − θ0)DT ‖F = op(1).
This shows part (d).
Part (e) is assumed.
Part (f) is trivial if WT = I. Assume now WT = (CĜ(T
−1∑T
t=1 ûtû
′
t)Ĝ
′C′)−1. Then,
1
T
T∑
t=1
ûtû
′
t = (I − B̂)
(
1
T
T∑
t=1
YtY
′
t
)
(I − B̂)′ − (I − B̂)
(
1
T
T∑
t=1
Yt
)
â′ − â
(
1
T
T∑
t=1
Y ′t
)
(I − B̂)′ + ââ′
→ E[utu′t],
by ergodicity and Assumption 1(b). Therefore, ŴT →p W = (CGE[utu′t]G′C′)−1.
This concludes part (i) of Lemma 3.
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(ii) Assume Condition CO holds.
By Lemma 1, Assumption 1 holds. This shows Part (a).
By (10), ut is a linear combination of λ
o
t and t, so {ut}t≥1 is ergodic and has finite first moment.
This shows Part (b).
Now we show Part (c). Let
DT =
1 0
0
√
T · IN
 .
Then, we have
max
t≤T+1
‖D−1T xt‖ =
√
1 +
(
max
t≤T+1
‖T−1/2Yt‖
)2
≤
√√√√1 + N∑
i=1
(
max
t≤T+1
|T−1/2yi,t|
)2
≤
√√√√1 + N∑
i=1
(
T−1/2|αi|+ max
t≤T+1
|T−1/2yi,t(0)|
)2
=
√√√√1 + N∑
i=1
(o(1) +Op(1))
2
= Op(1)
The second equality is because
max
t≤T+1
|T−1/2yi,t(0)| = max
r∈[0,1]
|(T + 1)−1/2yi,[r(T+1)](0)| ⇒ max
r∈[0,1]
νi(r)
by the continuous mapping theorem.
To show Part (d), we combine (9) and (11), and have
‖DT (β̂i − βi)‖ =
∥∥∥∥∥∥∥
 âi − ai√
T (̂bi − bi)

∥∥∥∥∥∥∥ = op(1).
Therefore,
‖(θ̂ − θ0)DT ‖F =
√√√√ N∑
i=1
‖DT (β̂i − βi)‖2 = op(1).
The second half of Part (d) is also satisfied since θ̂(t) = θ̂ for each t.
Part (e) is assumed and Part (f) is trivial for WT = I.
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Proof of Theorem 3. We use similar strategy as we do in the proof of Theorem 2. Let
L1,T () =
{
‖(θ̂ − θ0)DT ‖F ≤ , max
t=1,...,T
‖(θ̂(t) − θ0)DT ‖F ≤ 
}
,
L2,T (c) =
{
max
t≤T+1
‖D−1T xt‖ ≤ c
}
,
L3,T (η) =
{
‖Ĝ′C′WTCĜ−G′C′WCG‖F < η
}
.
By Assumption 3(d), there exists a positive sequence {T }T≥1 such that T → 0 and Pr(L1,T (T ))→
1. Let cT = 1/
√
T . So we have cT → ∞ and cT T → 0. By Assumption 2(c), we must have
Pr(L2,T (cT )) → 1. By Assumption 1(c) and Assumption 2(f), there exists a positive sequence {ηT }T≥1
such that ηT → 0 and Pr(L3,T (ηT )) → 1. Let LT = L1,T (T ) ∩ L2,T (cT ) ∩ L3,T (ηT ), then we have
Pr(LT )→ 1 and Pr(LcT )→ 0.
Suppose LT holds. Then, for some θ = θ̂ or θ = θ̂
(t) and for some t = 1, . . . , T , we have
|P̂t(θ)− Pt(θ0)| ≤ |P̂t(θ)− Pt(θ)|+ |Pt(θ)− Pt(θ0)|. (17)
Note that
|P̂t(θ)− Pt(θ)| =
∣∣∣(Yt − θxt)′(Ĝ′C′WTCĜ)−G′C′WCG)(Yt − θxt)∣∣∣
≤ ‖Yt − θxt‖2‖(Ĝ′C′WTCĜ−G′C′WCG‖F
≤ ‖ut + (θ0 − θ)xt‖2 · ηT
≤ (‖ut‖+ ‖(θ0 − θ)DTD−1T xt‖)2ηT
≤ (‖ut‖+ ‖(θ0 − θ)DT ‖F ‖D−1T xt‖)2ηT
≤ (‖ut‖+ T cT )2ηT (18)
and
|Pt(θ)− Pt(θ0)| = |(Yt − θxt)′G′C′WCG(Yt − θxt)− (Yt − θ0xt)′G′C′WCG(Yt − θ0xt)|
≤ |(Yt − θxt)′G′C′WCG(Yt − θxt)− (Yt − θxt)′G′C′WCG(Yt − θ0xt)|
+ |(Yt − θxt)′G′C′WCG(Yt − θ0xt)− (Yt − θ0xt)′G′C′WCG(Yt − θ0xt)|
= |(ut + (θ0 − θ)xt)′G′C′WCG(θ0 − θ)xt|+ |((θ0 − θ)xt)′G′C′WCGut|
≤ ‖ut + (θ0 − θ)DTD−1T xt‖‖G′C′WCG‖F ‖(θ0 − θ)DTD−1T xt‖
+ ‖(θ0 − θ)DTD−1T xt‖‖G′C′WCG‖F ‖ut‖
≤ (‖ut‖+ T cT )‖G′C′WCG‖F T ct + T cT ‖G′C′WCG‖F ‖ut‖
= (2‖ut‖+ T cT )‖G′C′WCG‖F T ct. (19)
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Combining (17), (18), and (19), we have
|P̂t(θ)− Pt(θ0)| ≤ g(T , cT , ηT ),
where
gt(T , cT , ηT ) = (‖ut‖+ T cT )2ηT + (2‖ut‖+ T cT )‖G′C′WCG‖F T ct.
By Assumption 1(a), gt(T , cT , ηT ) is identically distributed across t for a fixed T .
To show part (a), note that under null,
P = (Cα̂− d)′WT (Cα̂− d)
= (C(α+GuT+1 + op(1))− d)′(W + op(1))(C(α+GuT+1 + op(1))− d)
= (CGuT+1 + op(1))
′(W + op(1))(CGuT+1 + op(1))
= u′T+1G
′C′WCGuT+1 + op(1).
The second equality is by Theorem 1. Since P∞ = u′1G
′C′WCGu1, we have P →d P∞ by stationary of
{ut}t≥1.
Part (b)-(d) can be shown using the same strategy as in the proof of Theorem 2, with gt(T , cT , ηT )
in place of gt(T , cT ), and θ in place of β, so is omitted here.
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